- Home
- WATT vs CRIS Comparison
WATT vs CRIS Comparison
Compare WATT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WATT | CRIS |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 14.6M |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WATT | CRIS |
|---|---|---|
| Price | $5.20 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 406.5K | ★ 1.1M |
| Earning Date | 02-26-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,018,000.00 | ★ $11,650,000.00 |
| Revenue This Year | $509.64 | $6.13 |
| Revenue Next Year | $210.44 | $7.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 600.23 | 13.56 |
| 52 Week Low | $3.62 | $0.77 |
| 52 Week High | $22.20 | $3.65 |
Technical Indicators
Market Signals| Indicator | WATT | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 34.44 |
| Support Level | $4.80 | $0.80 |
| Resistance Level | $8.20 | $0.93 |
| Average True Range (ATR) | 0.69 | 0.08 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 35.92 | 30.93 |
Price Performance
Historical ComparisonAbout WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.